Amazon & Google Are Trying to Reshape the Medical Industry
NEW YORK (Reuters) – Amazon.com Inc is in a race against Google Inc to store data on human DNA, seeking both bragging rights in helping scientists make new medical discoveries and market share in a business that may be worth $1 billion a year by 2018.
Academic institutions and healthcare companies are picking sides between their cloud computing offerings – Google Genomics or Amazon Web Services – spurring the two to one-up each other as they win high-profile genomics business, according to interviews with researchers, industry consultants and analysts.
Be the first to know
Subscribe to receive the latest B2B marketing research, whitepapers, articles, infographics, ML news, and more.